FDA poised to issue full approval for Pfizer vaccine

pharmafile | August 23, 2021 | News story | Sales and Marketing  

The FDA is on track to issue full approval for its Pfizer vaccine.

 The New York Times reported that the Pfizer shot will be the first of the coronavirus jabs to be cleared by the FDA.

The development is significant as the move will empower businesses and universities to require vaccinations and tip hesitant Americans toward getting the jab.

The Surgeon General, Vivek Murthy told CNN’s State of the Union: “We already know that there are many businesses and universities that have moved toward vaccine requirements.

“And I think it’s a very reasonable thing to do to create a safe environment.

“We’ve given it to hundreds of millions of people.

“We’ve seen that it’s doing its job. And that’s why we’re continuing to recommend that people get vaccinated starting today and … as soon as they can.”

Currently, 52% of Americans have been fully vaccinated.

Murthy told ABC’s This Week: “The vaccines are continuing to work remarkably well for preventing people from ending up in the hospital, and they are saving lives.

“But what we are seeing is a decline in the protection against mild to moderate disease, and so we are anticipating there may be an erosion in that important protection that we’re seeing today down the line.

“And that’s why, to stay ahead of this virus, we’re recommending that people start to get boosters the week of 20 September.”

Education Secretary, Miguel Cardona, told NBC’s Meet the Press: “Unfortunately, in those places that they’re using politics to block good practice, we’re seeing hospitalisations through the roof for young children. That’s unacceptable.

“Let’s get politics out of the way. Let the educational leaders and health experts make the decisions around how to keep students and staff safe.”

Lilly Subbotin

Related Content

No items found

Latest content